Analysis of the Global Tissue Diagnostics Market

Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories

Regular Price: USD 10,000

Special Price USD 8,500

15% OFF

* Required Fields

Regular Price: USD 10,000

Special Price USD 8,500

PAY BY INVOICE

Be the first to review this product

This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market shares for the segments. Major market drivers and restraints for the US and Western Europe are discussed. The base year is 2012, and the forecast period runs from 2013 to 2017. Key histo-pathology laboratories are listed, and an effort has been made to collect the distributors and local suppliers in emerging countries.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Scope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchExecutive Summary—3 Big PredictionsMarket OverviewMarket BackgroundMarket Background (continued)Market Background (continued) Market SegmentationGlobal Market PerspectiveDefining Healthcare Trends in the FutureDefining Healthcare Trends in the Future (continued)Competitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)New Market Opportunities (continued)New Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Forecasts and Trends—Total Tissue Diagnostics MarketMarket Engineering MeasurementsForecast Assumptions and DefinitionsForecast Assumptions and Definitions (continued)Global Revenue ForecastGlobal Revenue Forecast by SegmentGlobal Percent Revenue Forecast by RegionGlobal Revenue Forecast by RegionGlobal Revenue Forecast DiscussionGlobal Revenue Forecast Discussion (continued)Global Revenue Forecast Discussion (continued)Procurement ProcessCompetitive EnvironmentCompetitive EnvironmentProduct Analysis Product Analysis (continued) Top CompetitorsTop Competitors (continued)Top Competitors (continued)Top Competitors (continued)Top Competitors (continued)The US BreakdownMarket Analysis—US Tissue Diagnostics Market Key Findings—US Tissue Diagnostics Market PEST Analysis—US Tissue Diagnostics Market Drivers and Restraints—US Tissue Diagnostics MarketUS Market DriversUS Market RestraintsMarket Impact of Top TrendsForecasts and Trends—US Tissue Diagnostics MarketMarket Engineering Measurements—US Tissue Diagnostics Market Revenue Forecast—US Tissue Diagnostics Market Revenue Forecast Discussion—US Tissue Diagnostics MarketUS—Market Share by TierUS—Tier AnalysisUS—Tier Analysis (continued)US—Tier Analysis (continued)US—Companion Diagnostics PartnershipsUS—Pricing AnalysisUS—Pricing Analysis (continued)US—Changes to Pathology CPT CodesUS—Changes to Pathology CPT Codes (continued)US—Key Tissue Diagnostic Service ProvidersUS Pre-analytical SegmentRevenue Forecast—US Pre-analytical SegmentRevenue Forecast Discussion Pre-analytical Segment US Advance Stains SegmentRevenue Forecast—US Advance Stains SegmentRevenue Forecast Discussion—US Advance stains SegmentWestern European BreakdownMarket AnalysisKey Findings—Western European Tissue Diagnostics Market PEST Analysis—Western European Tissue Diagnostics Market PEST Analysis—Western European Tissue Diagnostics Market (continued)Drivers and Restraints—Western European Tissue Diagnostic MarketWestern European Market DriversWestern European Market RestraintsMarket Impact of Top 8 TrendsForecasts and Trends—Western European Tissue Diagnostic MarketMarket Engineering MeasurementsRevenue Forecast—Western European Tissue Diagnostics Market Revenue Forecast by Segment TypeRevenue Forecasts DiscussionRevenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)Western Europe—Market Share by TierWestern Europe—Tier AnalysisWestern Europe—Tier Analysis (continued)Western Europe—Tier Analysis (continued)Key Tissue Diagnostic Service Providers Key Tissue Diagnostic Service Providers (continued) Key Tissue Diagnostic Service Providers (continued) Western European Regional AnalysisTissue Diagnostics Market Outlook in Western EuropeWestern European Tissue Diagnostics Market—Percent Regional AnalysisGermanyGermany—OverviewGermany—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)FranceFrance—OverviewFrance—Revenue ForecastRevenue Forecast DiscussionUnited KingdomUK—OverviewUK—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)ItalyItaly—OverviewItaly—Revenue ForecastRevenue Forecast DiscussionSpainSpain—OverviewSpain—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)BeneluxBenelux OverviewBenelux—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)ScandinaviaScandinavia OverviewScandinavia—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)APAC and ROW BreakdownMarket AnalysisKey Findings—APAC and ROW Tissue Diagnostics Market PEST Analysis—APAC and ROW Tissue Diagnostics Market Forecasts and Trends—APAC and ROW Tissue Diagnostics MarketMarket Engineering MeasurementsRevenue Forecast—Total APAC and ROW Tissue Diagnostics MarketRevenue Forecast by Segment—APAC and ROW Tissue Diagnostics MarketRevenue Forecast Discussion Revenue Forecast Discussion (continued) Revenue Forecast Discussion (continued) APAC and ROW—Market Share by TierMarket Share Analysis APAC and ROWCountry TrendsCountry Trends (continued)Country Trends (continued)Country Trends (continued)Country Trends (continued)Country Trends (continued)Country Trends (continued)Key Companies to WatchAdvanced Cell Diagnostics (ACD) Biomarker Strategies LLCHistoRx (Genoptix a Novartis Company)The Last WordThe Last Word—Three Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)The Last Word—Discussion (continued)The Last Word—Discussion (continued)Legal DisclaimerAppendixList of ‘Other’ CompaniesTable of Pricing DataTable of Pricing Data (continued)Table of Pricing Data (continued)Table of Pricing Data (continued)Table of Pricing Data (continued)Table of Pricing Data (continued)US—Table of CPT Code DescriptionsUS—Table of Cancer Prevalence Trends to 2020US—Drivers ExplainedUS—Drivers Explained (continued)US—Drivers Explained (continued)US—Drivers Explained (continued)US—Restraints ExplainedUS—Restraints Explained (continued)US—Restraints Explained (continued)US—Restraints Explained (continued)Western Europe—Drivers ExplainedWestern Europe—Drivers Explained (continued)Western Europe—Drivers Explained (continued)Western Europe—Drivers Explained (continued)Western Europe—Restraints ExplainedWestern Europe—Restraints Explained (continued)Western Europe—Restraints Explained (continued)Western Europe—Restraints Explained (continued)Western Europe—Restraints Explained (continued)Western Europe—Restraints Explained (continued)Associated MultimediaDecision Support DatabaseDecision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Decision Support Database (continued)Market Engineering MethodologyLearn More—Next Steps




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.